Back to top
more

Dentsply Sirona (XRAY)

(Delayed Data from NSDQ)

$25.31 USD

25.31
2,756,380

+1.17 (4.85%)

Updated Aug 23, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 25% (188 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

XRAY vs. ALGN: Which Stock Is the Better Value Option?

XRAY vs. ALGN: Which Stock Is the Better Value Option?

Here's Why You Should Hold on to NEOGEN (NEOG) Stock for Now

Investors continue to be optimistic about NEOGEN (NEOG) on robust segmental and geographical growth.

Bruker Corporation (BRKR) Reports Solid Preliminary Q1 Revenues

Bruker's (BRKR) revenue improvement in the first quarter is likely to have been boosted by robust performance by all three of its BSI groups.

PRA Health (PRAH) Chosen by MedChi to Offer Telehealth Services

PRA Health's (PRAH) company, Care Innovations, gets selected by MedChi to provide remote patient monitoring services, thereby enabling better patient care.

Reasons to Hold on to Align Technology (ALGN) Stock for Now

Investors continue to be optimistic about Align Technology (ALGN) on solid customer adoption of Invisalign and iTero products.

Luminex (LMNX) to Get Acquired by DiaSorin for Around $1.8B

Luminex (LMNX) to be acquired by DiaSorin for around $1.8 billion. This is likely to advance its technology and solutions' foothold outside the United States.

Here's Why You Should Hold on to Cardinal Health (CAH) Stock

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.

Here's Why You Should Add Phibro (PAHC) to Your Portfolio

Investors continue to be optimistic about Phibro (PAHC), owing to its potential in Performance Products and consistent high demand for its nutritional specialty products.

Globus Medical (GMED) Hurt by Dull Global Growth, Low Margins

Pricing continues to remain a major headwind for Globus Medical (GMED).

Omnicell's (OMCL) Automated Dispensing Service Adopted by Aultman

Omnicell's (OMCL) Autonomous Pharmacy vision receives another boost with the latest service adoption by Aultman.

Illumina (ILMN) Preliminary Q1 Revenues Rebound, '21 View Up

Illumina's (ILMN) revenue improvement in the first quarter is likely to have been boosted by on-going business recovery.

Here's Why You Should Hold on to Bruker (BRKR) Stock for Now

Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.

Quest Diagnostics (DGX) Divests Minority Share of Q2 Solutions

Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.

Henry Schein's (HSIC) New Deal Boosts Ambulatory Surgery Market

Henry Schein's (HSIC) recent majority ownership in Stradis Healthcare will advance the former's commitment to offer specialty solutions to customers.

Integra's (IART) Neurosurgery Rebounds Despite Supply Issues

Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically,

Illumina's (ILMN) Grail Merger in Trouble as FTC Files Suit

According to FTC, the Illumina (ILMN) and Grail merger will diminish the scope of innovation in the U.S. market for MCED tests.

Surging Earnings Estimates Signal Upside for Dentsply (XRAY) Stock

Dentsply (XRAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why You Should Add DENTSPLY SIRONA (XRAY) to Your Portfolio

Investor confidence is high in the DENTSPLY SIRONA (XRAY) stock, thanks to solid prospects.

DENTSPLY SIRONA's (XRAY) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA (XRAY).

Here's Why You Should Retain Cooper Companies (COO) Now

Investors remain optimistic about Cooper Companies (COO) backed by strong CSI and CVI product portfolios and its continued leadership in the specialty lenses market.

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

DENTSPLY SIRONA (XRAY) at a 52-Week High: What's Driving It?

DENTSPLY SIRONA (XRAY) is optimistic about growth in CAD/CAM business arm along with its recent product launch and strategic buyouts.

DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates

DENTSPLY SIRONA (XRAY) witnesses consumable revenue growth in the fourth quarter.

Why Earnings Season Could Be Great for DENTSPLY (XRAY)

DENTSPLY (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.